AptarGroup, Inc. Common Stock (ATR)
137.20
+6.56 (5.02%)
NYSE · Last Trade: Nov 1st, 12:51 AM EDT
News & Press Releases
Aptar (ATR) Q3 2026 Earnings Call Transcriptfool.com
Russian deconsolidation and margin pressures offset strong sales growth across segments.
Via The Motley Fool · October 31, 2026
What AptarGroup (ATR) Said on Its Q3 Earnings Callmarketbeat.com
AptarGroup (NYSE:ATR) reported third-quarter 2026 sales growth across its three business segments, while adjusted profitability declined from the prior year as emergency medicine destocking and lower margins in Beauty and Closures weighed on results.
Reported sales rose 6% to just over $1 billion,
Via MarketBeat · October 30, 2026
AptarGroup (NYSE:ATR) Q3 2026: Revenue and EPS Beat, But Margin Pressure and Russia Charge Weigh on Reactionchartmill.com
Via Chartmill · October 29, 2026
Aptar Reports Third Quarter 2026 Results
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following third quarter results for the period ended September 30, 2026, as compared to the corresponding period of the last fiscal year.
By AptarGroup, Inc. · Via Business Wire · October 29, 2026
AptarGroup (NYSE:ATR) Tops Q2 Estimates, Shares Rise After Hourschartmill.com
Via Chartmill · July 30, 2026
AptarGroup Q1 2026: Pharma Destocking Drags Earnings as Core Sales Stall for NYSE:ATRchartmill.com
Via Chartmill · April 30, 2026
Aptar Increases Quarterly Dividend to $0.50 Per Share
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, an increase of approximately 4% from the previous quarterly dividend of $0.48 per share. The payment date is December 3, 2026, to stockholders of record as of November 12, 2026.
By AptarGroup, Inc. · Via Business Wire · October 29, 2026
Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma, effective January 1, 2027.
By AptarGroup, Inc. · Via Business Wire · October 22, 2026
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH) to advance the science of nose-to-brain (N2B) drug delivery.
By AptarGroup, Inc. · Via Business Wire · September 14, 2026
Aptar (ATR) Q2 2026 Earnings Call Transcriptfool.com
Record $1B revenue as pharma growth offsets margin pressure.
Via The Motley Fool · August 7, 2026
AptarGroup Q2 Earnings Call Highlightsmarketbeat.com
AptarGroup (NYSE:ATR) reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this
Via MarketBeat · July 31, 2026
Aptar Reports Second Quarter 2026 Results
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results for the period ended June 30, 2026, as compared to the corresponding period of the last fiscal year.
By AptarGroup, Inc. · Via Business Wire · July 30, 2026
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World’s Most Sustainable Companies 2026 by TIME for the third consecutive year. Aptar is ranked 261 out of 750 global companies evaluated by TIME and its partner Statista.
By AptarGroup, Inc. · Via Business Wire · July 27, 2026
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is August 20, 2026, to stockholders of record as of July 30, 2026.
By AptarGroup, Inc. · Via Business Wire · July 16, 2026
Aptar Named Among Top 100 of America’s Best Companies by TIME
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the America’s Best Companies 2026 by TIME. Aptar is ranked 83 out of 1000 companies evaluated by TIME and its partner Statista. Aptar is ranked within the top five companies in the Engineering, Manufacturing and Medical Technology category and is ranked in the top 10 companies nationwide for sustainability transparency.
By AptarGroup, Inc. · Via Business Wire · July 13, 2026
Aptar Releases 2025 Corporate Sustainability Report
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2025 Corporate Sustainability Report entitled Progress in Motion. The report highlights activities across Aptar’s global operations from January 1 through December 31, 2025, and summarizes certain milestones and progress measured across the company’s global sustainability strategy, which is focused on three key pillars:
By AptarGroup, Inc. · Via Business Wire · June 18, 2026
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier Engagement Leader, for the sixth consecutive year. This assessment, based on information reported within the 2025 CDP reporting cycle, highlights companies that are engaging their suppliers on climate change and supporting efforts to address emissions throughout the value chain.
By AptarGroup, Inc. · Via Business Wire · June 2, 2026
Aptar to Participate in Upcoming Investor Conferences
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences:
By AptarGroup · Via Business Wire · May 27, 2026
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballotmarketbeat.com
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early 2026 results.
President and Chief Executive Officer Stephan Tanda told shareholders that he p
Via MarketBeat · May 9, 2026
AptarGroup (ATR) Q1 2026 Earnings Transcriptfool.com
AptarGroup (ATR) Q1 2026 Earnings Transcript
Via The Motley Fool · May 1, 2026
Aptar Reports First Quarter 2026 Results
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended March 31, 2026, as compared to the corresponding period of the last fiscal year.
By AptarGroup, Inc. · Via Business Wire · April 30, 2026
Boston Trust Walden Lets Go of 93,000 Qualys (QLYS) Sharesfool.com
Qualys delivers cloud-based security and compliance solutions to enterprise and public sector clients across multiple industries.
Via The Motley Fool · April 26, 2026
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is May 27, 2026, to stockholders of record as of May 6, 2026.
By AptarGroup, Inc. · Via Business Wire · April 23, 2026
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, announced today that has been named one of America’s Climate Leaders by USA Today for the fourth consecutive year.
By AptarGroup, Inc. · Via Business Wire · April 22, 2026
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable’s preferred digital health partner for the enFuse® system. This digital solution will be designed to guide patients and caregivers throughout the injection process and help support engagement before, during, and after administration.
By Aptar Digital Health · Via Business Wire · April 8, 2026